The Influence of HLA Class II Antibodies on HTLV-III (“AIDS”) Antibody ELISA Results
Epidemiological data suggest, that the human T-cell-lymphotropic virus (HTLV-III) ist the causative agent of the acquired immune deficiency syndrome (AIDS). Based on virus antigen preparations of the infected leukemic H9 cell line, commercial HTLV-III ELISA tests have become available a few months ago. Screening for HTLV-III antibodies at every blood donation will probably become mandatory in the Federal Republic of Germany (FRG) after October 1, 1985 and is already now performed routinely in some blood banks. The number of reported AIDS cases is rapidly increasing in many European countries; with a rate of 6.6 per million population, Denmark and Belgium are the two countries with the highest rates (Table 1, MMWR 34/11, 147–150, 1985, CDC, Atlanta, USA).
KeywordsAcquire Immune Deficiency Syndrome Confirmatory Test Plasma Protein Fraction Collaborative Transplant Study Acquire Immune Deficiency Syndrome Case
Unable to display preview. Download preview PDF.